FDA issues Class I recall for warfarin test strips after patient strokes

17:10 EST 5 Nov 2018 | Cardiovascular Business

Thumbnail The FDA has announced a Class I recall for 1.1 million packages of CoaguChek XS PT test strips used with point-of-care or in-home devices to adjust warfarin dosing.

Original Article: FDA issues Class I recall for warfarin test strips after patient strokes

More From BioPortfolio on "FDA issues Class I recall for warfarin test strips after patient strokes"